1-3 of 3
Zoran Filipovic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A156: Preclinical activity of MDM2 antagonist RO6839921, a pegylated prodrug for intravenous administration

Brian Higgins, Christian Tovar, Kelli Glen, Aruna Railkar, Zoran Filipovic, Farooq Qureshi, Binh Vu, George Ehrlich, Dan Fishlock, Lin-Chi Chen, Steven Middleton, Gwen Nichols, Kathryn Packman, Lyubomir Vassilev
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): A156.
https://doi.org/10.1158/1535-7163.TARG-15-A156
Published: 01 December 2015
View article titled, Abstract A156: Preclinical activity of MDM2 antagonist RO6839921, a pegylated prodrug for intravenous administration
Journal Articles

Abstract B55: Antitumor activity of the MDM2 antagonist RG7388.

Brian Higgins, Christian Tovar, Kelli Glenn, Antje Walz, Zoran Filipovic, Yu-E Zhang, Markus Dangl, Bradford Graves, Lyubomir Vassilev, Kathryn Packman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B55.
https://doi.org/10.1158/1535-7163.TARG-13-B55
Published: 01 November 2013
View article titled, Abstract B55: Antitumor activity of the MDM2 antagonist RG7388.
Journal Articles

Macrophage inhibitory cytokine-1: A novel biomarker for p53 pathway activation

Hong Yang, Zoran Filipovic, David Brown, Samuel N. Breit, Lyubomir T. Vassilev
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (10): 1023–1029.
Published: 24 October 2003
View article titled, Macrophage inhibitory cytokine-1: A novel biomarker for p53 pathway activation
Open the PDF for Macrophage inhibitory cytokine-1: A novel biomarker for p53 pathway activation in another window